Post-Pandemic Resurgence of Pertussis in Southeastern Romania, 2024: Vaccination Gaps, Clinical Severity, and Regional Surveillance Performance
Vaccines · 04.07.2026 · 14 (7) · 595
DOI: 10.3390/vaccines14070595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 04.07.2026. Verfasst von Alina Plesea Condratovici und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, Medical-Pharmaceutical Research Center, "Dunarea de Jos" University of Galati, 800008 Galati, Romania. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Dunarea de Jos" University of Galati, "Dunarea de Jos" University of Galati.
Abstract (Originalsprache)
Background/Objectives: Following the COVID-19 pandemic, pertussis resurged sharply across Europe, with 209,674 cases reported in the EU/EEA in 2024. This study characterises the epidemiology of the 2024 pertussis resurgence across five counties of southeastern Romania, with emphasis on vaccination status, clinical severity, and regional surveillance performance.
Methods
A retrospective, population-based analysis was conducted on 452 cases notified between February 2024 and January 2025, extracted from the national surveillance database. A pre-specified reclassification of PCR-positive cases yielded 326 confirmed cases. Categorical, non-parametric, correlation, and multivariate logistic regression analyses were performed.
Results
The epidemic peaked in September 2024, with 56.0% of cases occurring between August and October. Children under five years accounted for 63.2% of confirmed cases, and 72.1% were not vaccinated according to age-appropriate schedule, predominantly due to parental refusal (43.0%) and non-attendance (36.6%). Pneumonia affected 36.8% of confirmed cases, ranging from 81.0% in infants under two months to 0% in adolescents. Age-appropriate vaccination was independently protective against pneumonia (adjusted OR = 0.53, 95% CI 0.29 to 0.96, p = 0.035; population attributable risk 37.3%). Significant inter-county heterogeneity was identified in PCR implementation (72 to 100%) and reporting delays.
Conclusions
Vaccination gaps were the principal modifiable driver of the resurgence, supporting targeted coverage improvement and the introduction of a national maternal Tdap programme.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Pharmacy, Medical-Pharmaceutical Research Center, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
ORCID-Profile: Alina Plesea Condratovici, Valerian Ionut Stoian, Catalin Plesea Condratovici, Ancuta Elena Tupu
Förderung
- "Dunarea de Jos" University of Galati
- "Dunarea de Jos" University of Galati
Zitieren
APA
Condratovici, A. P., Debita, M., Stoian, V. I., Condratovici, C. P., Tupu, A. E., & Tudor, S. S. (2026). Post-Pandemic Resurgence of Pertussis in Southeastern Romania, 2024: Vaccination Gaps, Clinical Severity, and Regional Surveillance Performance. Vaccines, 14(7), 595. https://doi.org/10.3390/vaccines14070595
Vancouver
Condratovici AP, Debita M, Stoian VI, Condratovici CP, Tupu AE, Tudor SS. Post-Pandemic Resurgence of Pertussis in Southeastern Romania, 2024: Vaccination Gaps, Clinical Severity, and Regional Surveillance Performance. Vaccines. 2026;14(7):595. doi:10.3390/vaccines14070595
BibTeX
@article{Condratovici2026,
author = {Condratovici, Alina Plesea and Debita, Mihaela and Stoian, Valerian Ionut and Condratovici, Catalin Plesea and Tupu, Ancuta Elena and Tudor, Simona Steliana},
title = {Post-Pandemic Resurgence of Pertussis in Southeastern Romania, 2024: Vaccination Gaps, Clinical Severity, and Regional Surveillance Performance},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {7},
pages = {595},
doi = {10.3390/vaccines14070595}
}
EUVIMED